In October 2023, a cholera outbreak surfaced in Lusaka, Zambia. Machine learning techniques were used to investigate if THINKMD’s data exhibited syndromic signals related to diarrheal illnesses that could have forewarned of the cholera outbreak risk.
After 18 months of dedication and hard work by our clinical and engineering teams, Version 5.0 of THINKMD’s clinical intelligence platform has been released.
After two years of commitment to the THINKMD team, CEO Chris Powell will be stepping down from his co-lead operational role and transitioning to become an advisor for the company. Co-founder and company co-leader, Barry Finette M.D., Ph.D, will lead THINKMD as it prepares for a significant era of growth in 2024.
THINKMD has been awarded a $1.5 million grant by Development Innovative Ventures (DIV), the United States Agency for International Development’s (USAID) open innovation program.
The clock is ticking on the 2030 Sustainable Development Agenda and there needs to be more emphasis on partnerships and better use of data and digital technology. A note from THINKMD CEO, Chris Powell.
In a new partnership with VF Corporation, THINKMD will implement its clinical intelligence solutions and data analytics offering into footwear and apparel factories in Cambodia to improve health outcomes for factory workers, with the ultimate goal of strengthening...
In the THINKMD July 2022 newsletter, we discuss the road to digital health adoption, the Ukraine crisis and introduce new board and team members.
THINKMD will be hosting a series of opportunities to provide an accessible platform for global health dialogue, in the from of Virtual Open MIC events.
In 2020, as a global pandemic erupted, Alight and THINKMD were able to quickly pivot their focus and expand the services they provide to include screening and diagnostic capabilities directly related to COVID-19 through a decentralized technology network. This allowed the teams to get a better handle on tracking the virus amongst vulnerable migrant populations.